T. Rowe Price Investment Management, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 1897612
BALTIMORE, MD
Position in CRSP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$140,454,944
-$28,747,697 QoQ
Shares Held
2,952,595
-8.5% QoQ
Ownership
3.06%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 99.57776125747012.ToString("F0")%
Shared 0.ToString("F0")%
None 0.42223874252987625.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. CRSP ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,315,111 | |
| 2 | ASND |
Ascendis Pharma A/S
|
6,162,042 | $1,409,443,866 | |
| 3 | CYTK |
Cytokinetics Inc
|
17,523,840 | $1,154,996,294 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,033,823 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,642,847 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,146,572 | |
| 7 | BNTX |
BioNTech SE
|
5,856,073 | $520,487,768 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,481,337 |
All Filings in CRSP
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $140,454,944 | 2,952,595 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $169,202,641 | 3,226,595 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $212,744,269 | 3,282,584 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $179,142,384 | 3,683,026 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $129,249,445 | 3,798,103 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $150,028,826 | 3,811,708 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $128,606,340 | 2,737,470 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $147,482,514 | 2,730,652 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $184,327,200 | 2,704,331 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $226,060,243 | 3,611,186 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $165,756,699 | 3,651,833 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $204,719,113 | 3,646,582 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $165,739,500 | 3,664,371 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $121,688,905 | 2,993,577 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $146,478,430 | 2,241,445 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||